McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed Feb 19, 2020
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Tax Payment
Common Stock
2020-02-15$25.33/sh−864$21,885→ 23,453 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 2,500 shares. The RSA vests in three equal annual installments from February 15, 2019, subject to Mrs. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The fair market value was determined on February 14, 2020 pursuant to the Plan.